Selected research
Market Structure
Global Female Infertility Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Female Infertility Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Female Infertility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Female Infertility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Female Infertility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Female Infertility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Female Infertility Drugs include Allergan Plc, Ferring BV, Merck KGaA, Novartis AG and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Female Infertility Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Female Infertility Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Female Infertility Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Female Infertility Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Female Infertility Drugs Segment by Company
Allergan Plc
Ferring BV
Merck KGaA
Novartis AG
Sanofi
Female Infertility Drugs Segment by Type
Parenteral
Oral
Others
Female Infertility Drugs Segment by Application
Low Birth Weight
Multiple-gestation Pregnancies
Multiple-birth Infants
Ovarian Hyperstimulation Syndrome
Risk of Cesarean Delivery
Premature Labor
Female Infertility Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female Infertility Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Female Infertility Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female Infertility Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Female Infertility Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Female Infertility Drugs industry.
Chapter 3: Detailed analysis of Female Infertility Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Female Infertility Drugsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Parenteral
- Oral
- Others
Applications
- Low Birth Weight
- Multiple-gestation Pregnancies
- Multiple-birth Infants
- Ovarian Hyperstimulation Syndrome
- Risk of Cesarean Delivery
- Premature Labor
Companies covered
- Allergan Plc
- Ferring BV
- Merck KGaA
- Novartis AG
- Sanofi
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Female Infertility Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Parenteral
- 1.2.3 Oral
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Female Infertility Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Low Birth Weight
- 1.3.3 Multiple-gestation Pregnancies
- 1.3.4 Multiple-birth Infants
- 1.3.5 Ovarian Hyperstimulation Syndrome
- 1.3.6 Risk of Cesarean Delivery
- 1.3.7 Premature Labor
- 1.4 Global Market Growth Prospects
- 1.5 Global Female Infertility Drugs Growth Trends by Region
- 1.5.1 Global Female Infertility Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Female Infertility Drugs Market Size by Region (2021-2026)
- 1.5.3 Female Infertility Drugs Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Female Infertility Drugs Market Dynamics
- 2.1 Female Infertility Drugs Industry Trends
- 2.2 Female Infertility Drugs Industry Drivers
- 2.3 Female Infertility Drugs Industry Opportunities and Challenges
- 2.4 Female Infertility Drugs Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Female Infertility Drugs Revenue by Company (2021-2026)
- 3.2 Global Female Infertility Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Female Infertility Drugs Key Company Head office and Area Served
- 3.4 Global Female Infertility Drugs Company, Product Type & Application
- 3.5 Global Female Infertility Drugs Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Female Infertility Drugs Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Female Infertility Drugs Players Market Share by Revenue in 2025
- 3.6.3 2025 Female Infertility Drugs Tier 1, Tier 2, and Tier 3
4 Female Infertility Drugs Market by Type
- 4.1 Global Female Infertility Drugs Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Female Infertility Drugs Market Size by Type (2021-2032)
- 4.3 Global Female Infertility Drugs Market Size Share by Type (2021-2032)
5 Female Infertility Drugs Market by Application
- 5.1 Global Female Infertility Drugs Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Female Infertility Drugs Market Size by Application (2021-2032)
- 5.3 Global Female Infertility Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Allergan Plc
- 6.1.1 Allergan Plc Company Information
- 6.1.2 Allergan Plc Business Overview
- 6.1.3 Allergan Plc Female Infertility Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Allergan Plc Female Infertility Drugs Product Portfolio
- 6.1.5 Allergan Plc Recent Developments
- 6.2 Ferring BV
- 6.2.1 Ferring BV Company Information
- 6.2.2 Ferring BV Business Overview
- 6.2.3 Ferring BV Female Infertility Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Ferring BV Female Infertility Drugs Product Portfolio
- 6.2.5 Ferring BV Recent Developments
- 6.3 Merck KGaA
- 6.3.1 Merck KGaA Company Information
- 6.3.2 Merck KGaA Business Overview
- 6.3.3 Merck KGaA Female Infertility Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Merck KGaA Female Infertility Drugs Product Portfolio
- 6.3.5 Merck KGaA Recent Developments
- 6.4 Novartis AG
- 6.4.1 Novartis AG Company Information
- 6.4.2 Novartis AG Business Overview
- 6.4.3 Novartis AG Female Infertility Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Novartis AG Female Infertility Drugs Product Portfolio
- 6.4.5 Novartis AG Recent Developments
- 6.5 Sanofi
- 6.5.1 Sanofi Company Information
- 6.5.2 Sanofi Business Overview
- 6.5.3 Sanofi Female Infertility Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Sanofi Female Infertility Drugs Product Portfolio
- 6.5.5 Sanofi Recent Developments
7 North America
- 7.1 North America Female Infertility Drugs Market Size (2021-2032)
- 7.2 North America Female Infertility Drugs Market Size by Type
- 7.2.1 North America Female Infertility Drugs Market Size by Type (2021-2026)
- 7.2.2 North America Female Infertility Drugs Market Size by Type (2027-2032)
- 7.2.3 North America Female Infertility Drugs Market Share by Type (2021-2032)
- 7.3 North America Female Infertility Drugs Market Size by Application
- 7.3.1 North America Female Infertility Drugs Market Size by Application (2021-2026)
- 7.3.2 North America Female Infertility Drugs Market Size by Application (2027-2032)
- 7.3.3 North America Female Infertility Drugs Market Share by Application (2021-2032)
- 7.4 North America Female Infertility Drugs Market Size by Country
- 7.4.1 North America Female Infertility Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Female Infertility Drugs Market Size by Country (2021-2026)
- 7.4.3 North America Female Infertility Drugs Market Size by Country (2027-2032)
- 7.4.4 North America Female Infertility Drugs Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Female Infertility Drugs Market Size (2021-2032)
- 8.2 Europe Female Infertility Drugs Market Size by Type
- 8.2.1 Europe Female Infertility Drugs Market Size by Type (2021-2026)
- 8.2.2 Europe Female Infertility Drugs Market Size by Type (2027-2032)
- 8.2.3 Europe Female Infertility Drugs Market Share by Type (2021-2032)
- 8.3 Europe Female Infertility Drugs Market Size by Application
- 8.3.1 Europe Female Infertility Drugs Market Size by Application (2021-2026)
- 8.3.2 Europe Female Infertility Drugs Market Size by Application (2027-2032)
- 8.3.3 Europe Female Infertility Drugs Market Share by Application (2021-2032)
- 8.4 Europe Female Infertility Drugs Market Size by Country
- 8.4.1 Europe Female Infertility Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Female Infertility Drugs Market Size by Country (2021-2026)
- 8.4.3 Europe Female Infertility Drugs Market Size by Country (2027-2032)
- 8.4.4 Europe Female Infertility Drugs Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Female Infertility Drugs Market Size (2021-2032)
- 9.2 China Female Infertility Drugs Market Size by Type
- 9.2.1 China Female Infertility Drugs Market Size by Type (2021-2026)
- 9.2.2 China Female Infertility Drugs Market Size by Type (2027-2032)
- 9.2.3 China Female Infertility Drugs Market Share by Type (2021-2032)
- 9.3 China Female Infertility Drugs Market Size by Application
- 9.3.1 China Female Infertility Drugs Market Size by Application (2021-2026)
- 9.3.2 China Female Infertility Drugs Market Size by Application (2027-2032)
- 9.3.3 China Female Infertility Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Female Infertility Drugs Market Size (2021-2032)
- 10.2 Asia Female Infertility Drugs Market Size by Type
- 10.2.1 Asia Female Infertility Drugs Market Size by Type (2021-2026)
- 10.2.2 Asia Female Infertility Drugs Market Size by Type (2027-2032)
- 10.2.3 Asia Female Infertility Drugs Market Share by Type (2021-2032)
- 10.3 Asia Female Infertility Drugs Market Size by Application
- 10.3.1 Asia Female Infertility Drugs Market Size by Application (2021-2026)
- 10.3.2 Asia Female Infertility Drugs Market Size by Application (2027-2032)
- 10.3.3 Asia Female Infertility Drugs Market Share by Application (2021-2032)
- 10.4 Asia Female Infertility Drugs Market Size by Country
- 10.4.1 Asia Female Infertility Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Female Infertility Drugs Market Size by Country (2021-2026)
- 10.4.3 Asia Female Infertility Drugs Market Size by Country (2027-2032)
- 10.4.4 Asia Female Infertility Drugs Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Female Infertility Drugs Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Female Infertility Drugs Market Size by Type
- 11.2.1 South America, Middle East & Africa Female Infertility Drugs Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Female Infertility Drugs Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Female Infertility Drugs Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Female Infertility Drugs Market Size by Application
- 11.3.1 South America, Middle East & Africa Female Infertility Drugs Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Female Infertility Drugs Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Female Infertility Drugs Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Female Infertility Drugs Market Size by Country
- 11.4.1 South America, Middle East & Africa Female Infertility Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Female Infertility Drugs Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Female Infertility Drugs Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Female Infertility Drugs Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst